产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
贝那普利是一种长效的血管紧张素转换酶 (ACE) 抑制剂。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAB0978 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C24H28N2O5 · HCl |
| 分子量 | 460.95 |
| MDL编号 | MFCD00895734 |
| NACRES | NA.24 |
产品性质
| 质量水平 | 300 |
| 等级 | certified reference material pharmaceutical secondary standard |
| 形式 | powder |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 250 mg |
| application(s) | pharmaceutical |
| 药典可追溯性 | traceable to PhEur Y0001025 traceable to USP 1048619 |
| 储存温度 | 2-8℃ |
| SMILES string | Cl[H].CCOC(=O)[C@H](CCc1ccccc1)N[C@H]2CCc3ccccc3N(CC(O)=O)C2=O |
| InChI | 1S/C24H28N2O5.ClH/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28;/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28);1H/t19-,20-;/m0./s1 |
| InChI key | VPSRQEHTHIMDQM-FKLPMGAJSA-N |
| Gene Information | human ... ACE(1636) |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H361fd |
| 预防措施声明 | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| 危险分类 | Repr. 2 |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 2 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
SUPELCO
m.cnreagent.com
